Identification of genetic variants of the IL‐22 gene in association with an altered risk of COPD susceptibility. (9th July 2022)

• Record Type: Journal Article
• Authors: Wang, Yan; Zhou, Qipeng; Chen, Lingzhu; Dong, Lian; Xiong, Mingmei; Xie, Xiaohui; Zhao, Li; Xu, Jingyi; Zheng, Zeguang; Wang, Jian; Lu, Wenju
• Is Part Of: Clinical respiratory journal. Volume 16:Number 8(2022)
• Page Start: 537
• Page End: 545
• Publication Date: 2022-07-09
• Subjects: COPD -- IL22 -- promoter region activity -- SNP; Respiratory organs -- Diseases -- Periodicals; Respiratory organs -- Periodicals; 616.24
• DOI: 10.1111/crj.13517
• Languages: English
• ISSNs: 1752-6981

Abstract

Abstract: The incidence of chronic obstructive pulmonary disease (COPD) is related to the interaction between environmental exposure and genetic factors. Far more than 15% of smokers eventually develop COPD. In addition to smoking, genetic susceptibility may be another factor in the development of COPD. IL‐22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis. Here, we conducted a case–control study to evaluate the association between IL‐22 tag‐single nucleotide polymorphisms (SNPs) and COPD risk. Four tag‐SNPs (rs2227478, rs2227481, rs2227484 and rs2227485) were identified according to linkage disequilibrium (LD) analysis in 30 healthy controls. A total of 513 COPD cases and 504 controls were recruited to perform an association study between these four tag‐SNPs and COPD risk. We found that the "C" allele of rs2227478T>C and the "T" allele of rs2227481C>T were obviously related to decreased COPD susceptibility. Genetic model analysis showed that rs2227478T>C and rs2227481C>T were significantly associated with a decreased risk of COPD under dominant models after adjusting for the above factors. In the recessive model, rs2227485T>C was obviously associated with decreased COPD risk. Our data showed that only rs2227485T>C was associated with a decreased COPD risk after Bonferroni correction. The eQTL analysis showed that rs2227485T>C was significantly associated with IL‐22 expression. The pGL4‐rs2227485‐C gene reporter had a higher promoter activity than pGL4‐rs2227485‐T. In our study, rs2227485T>C, located in the promoter region of IL‐22, was associated with a decreased risk of COPD and increased IL‐22 promoter activity, suggesting that this variant might modulate COPD susceptibility. Abstract : The rs2227485T>C, located in the promoter region of IL‐22, was associated with a decreased risk of chronic obstructive pulmonary disease (COPD) and increased IL‐22 promoter activity, suggesting that this variant might modulate COPD susceptibility.